Canada - University of Calgary - Advanced Contract Award Notice / Notice of Proposed Procurement - GemCell Human Serum
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 07 February 2025
- Opportunity publication date
- 31 January 2025
- Value of contract
- to be confirmed
- Your guide to exporting
Description
The University of Calgary (UCalgary) intends to purchase the GemCell™ Plus Xeno-free Human Serum (AB Serotype) and GemCell™ U.S. Origin Human Serum (AB Serotype) from Stellar Scientific. The GemCell™ Human Serum is a critical component in the validated processes supporting UCalgary Riddell Centre for Cancer Immunotherapy’s CAR T cell manufacturing program and Clinical Trial Application (CTA) to Health Canada. This specific serum lot has been used extensively in the lab for validation work, and its characteristics ensure it meets the stringent requirements for clinical-grade applications. It is Riddell Centre’s understanding that only Stellar Scientific’s GemCell Human Serum can meet their specific requirements for clinical CAR T cell manufacturing and their Clinical Trial Application.
- Opportunity closing date
- 07 February 2025
- Value of contract
- to be confirmed
About the buyer
- Address
- University of Calgary
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.